Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page
- Check4 days agoChange DetectedRecord History now shows 'No longer looking for participants,' indicating recruitment has ended for the study. It also records a new revision tag 'Revision: v3.6.0' and removes the prior 'Revision: v3.5.5' entry from the history.SummaryDifference0.3%

- Check11 days agoChange DetectedThe history page now shows a new release identifier Revision: v3.5.5, replacing the previous v3.5.4. This reflects a software update to the ClinicalTrials.gov interface rather than changes to the trial data or displayed content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history includes an added Revision: v3.5.4, replacing the prior v3.5.3 in the sequence of revisions.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s interface revision has been updated from v3.5.2 to v3.5.3, reflecting a change to the system/version display rather than any study record content.SummaryDifference0.1%

- Check61 days agoChange DetectedThe record history shows the addition of revision v3.5.2 and the deletion of revision v3.5.0.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.